Assessment of vaccine efficacy by challenge studies in man
- 1 June 1976
- journal article
- clinical trial
- Published by Oxford University Press (OUP)
- Vol. 52 (608) , 379-380
- https://doi.org/10.1136/pgmj.52.608.379
Abstract
Summary: The only final test of the potency of a vaccine is its ability to protect against exposure in an epidemic. Laboratory tests for control purposes attempt to predict this capacity. It is suggested that challenging small groups of volunteers with attenuated influenza virus is a good index of immunity which could be used to check and refine present tests and to evaluate new ones.Keywords
This publication has 4 references indexed in Scilit:
- Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccineArchiv für die gesamte Virusforschung, 1975
- Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection.1973
- Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2/Hong Kong/68 (H3N2) influenza vaccines A report to the Medical Research Council Committee on Influenza and other Respiratory Virus VaccinesEpidemiology and Infection, 1972
- A COMPARISON OF LIVE AND KILLED INFLUENZA-VIRUS VACCINES: Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus VaccinesThe Lancet, 1968